Workaholism and work-family interaction among emergency and critical care nurses.

OBJECTIVES: Investigating the prevalence of workaholism as well as the relationship between work-family interaction among emergency and critical care nurses. RESEARCH METHODOLOGY/DESIGN: A quantitative cross-sectional study. SETTING: A total of 219 nurses took part in the Dutch Work Addiction Scale (DUWAS-10) and the Survey Work-Home Interaction Nijmegen (SWING), which included socio-demographic and occupational question. Data was gathered in Spain between June and September 2019. RESULTS: Workaholism was found to be prevalent in 28.3% of the participants. In all four categories, workaholism was statistically connected to work-home interaction, with workaholics having higher means than non-workaholics. Perceived work stress was related to workaholism (p =.036). In the Work Excessively dimension, female nurses had significantly higher mean scores (M = 2.26) than their male counterparts (M = 1,88). In addition, in the Negative Work-Home Interaction (M = 2.04), the global mean scores were higher than in the Negative Home-Work Interaction (M = 1.34), indicating conflict and a negative impact of work on the family. CONCLUSION: The findings of this study demonstratedthe necessity of taking into account demands and resources from both the work and home domains since it has been shown that both have an impact on one other. Furthermore, given the vital responsibilities that emergency and critical care nurses play in the health care system, our findings suggest that occupational health treatments should be used to identify those working profiles that are particularly at risk.

Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.

Rationale: The natural history of recovery from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unknown. Because fibrosis with persistent physiological deficit is a previously described feature of patients recovering from similar coronaviruses, treatment represents an early opportunity to modify the disease course, potentially preventing irreversible impairment.Objectives: Determine the incidence of and describe the progression of persistent inflammatory interstitial lung disease (ILD) following SARS-CoV-2 when treated with prednisolone.Methods: A structured assessment protocol screened for sequelae of SARS-CoV-2 pneumonitis. Eight hundred thirty-seven patients were assessed by telephone 4 weeks after discharge. Those with ongoing symptoms had outpatient assessment at 6 weeks. Thirty patients diagnosed with persistent interstitial lung changes at a multidisciplinary team meeting were reviewed in the interstitial lung disease service and offered treatment. These patients had persistent, nonimproving symptoms.Results: At 4 weeks after discharge, 39% of patients reported ongoing symptoms (325/837) and were assessed. Interstitial lung disease, predominantly organizing pneumonia, with significant functional deficit was observed in 35/837 survivors (4.8%). Thirty of these patients received steroid treatment, resulting in a mean relative increase in transfer factor following treatment of 31.6% (standard deviation [SD] ± 27.6, P < 0.001), and forced vital capacity of 9.6% (SD ± 13.0, P = 0.014), with significant symptomatic and radiological improvement.Conclusions: Following SARS-CoV-2 pneumonitis, a cohort of patients are left with both radiological inflammatory lung disease and persistent physiological and functional deficit. Early treatment with corticosteroids was well tolerated and associated with rapid and significant improvement. These preliminary data should inform further study into the natural history and potential treatment for patients with persistent inflammatory ILD following SARS-CoV-2 infection.